
Pharmacally
TB Vaccine Program
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in TB Vaccine Program
ManufacturingGates MRI Taps GSK’s AS01E Adjuvant and Serum Institute of India’s Manufacturing Scale to Advance M72/AS01E TB Vaccine ProgramThe Gates Medical Research Institute has selected Serum Institute of India as the manufacturing partner for M72/AS01E, an investigational tuberculosis vaccine currently in Phase 3 testing.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.